As of 2024-12-13, the Fair Value of Travere Therapeutics Inc (TVTX) is -20.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.32 USD, the upside of Travere Therapeutics Inc is -218.36%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -146.40 | -169.40 | -180.10 | -278.50 | -111.40 | -177.16 |
| YoY growth | -42.55% | -15.71% | -6.32% | -54.64% | 60.00% | -11.84% |
| Market Cap (mil) | 1,484.67 |
| P/E | |
| Forward P/E |
| EPS | -4.10 |
| Avg earnings growth rate | -11.84% |
| TTM earnings | -351.45 |